← Eichor
Study identifier: NCT06820931 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Indicators and Evaluation of Efficacy of Yin-nourishing and Fire-reducing Chinese Medicine for Girls With Rapid Progression of Early Puberty

Condition: Puberty Changes  ·  Sponsor: Children's Hospital of Fudan University

PhasePhase 4
Planned participants80
Who can joinFemale, 8 Years to 9 Years
Healthy volunteersNo

About this study

1\. Evaluate whether AMH and SHBG have differential expression before and after the diagnosis of rapid and slow progression types of early puberty and whether this difference has a predictive effect on the rapid progression type. 2. Assess the therapeutic effect of nourishing yin and purging fire traditional Chinese medicine on girls with rapid progression type of early puberty providing a standardized clinical basis for the formulation of diagnostic and treatment guidelines (or protocols) for the rapid progression type of early puberty using traditional Chinese medicine

This description comes directly from the study's public registry record.

Talk to the study team

Wen Sun  ·  8613818844692  ·  sunwenhere@163.com

Teng Fan  ·  8619921314120  ·  fantengcn@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Children's Hospital of Fudan UniversityShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06820931